Omega-3 and Choline Composition for Cognitive Aging
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Existing nutritional interventions for cognitive aging have focused on administering nutrients in isolation rather than in combination, leading to inconsistent results, and have failed to effectively target multiple risk factors associated with cognitive decline.
Innovation Solution
A method involving the administration of a composition comprising omega-3 fatty acids, such as docosahexaenoic acid and eicosapentaenoic acid, combined with choline, along with optional nitric oxide releasing compounds like citrulline, to target different risk factors associated with cognitive decline, thereby attenuating cognitive aging.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If nutrients are administered in isolation, then the intervention is simple to implement, but the results are inconsistent and ineffective in targeting multiple risk factors
Solution Approach 1:
The patent combines multiple nutrients (omega-3 fatty acids, choline, B vitamins, antioxidants) into a single composite nutritional intervention. This merging approach allows the formulation to simultaneously target multiple risk factors for cognitive decline including oxidative stress, inflammation, homocysteine levels, and neuronal membrane health, thereby producing consistent cognitive benefits that single-nutrient interventions failed to achieve
2Reliability
If a combination of nutrients is used to target multiple risk factors, then the effectiveness in preventing cognitive decline improves, but the complexity of the intervention increases
Solution Approach 1:
The nutritional formulation is designed with multi-functionality, where each component serves multiple purposes: omega-3 fatty acids support neuronal membrane integrity and reduce inflammation; choline supports acetylcholine synthesis and membrane structure; B vitamins (particularly B6, B12, and folate) work together to reduce homocysteine levels; and antioxidants combat oxidative stress. This universal approach allows a single intervention to address multiple pathological pathways simultaneously, improving effectiveness while managing complexity through integrated design
3Device complexity
If single nutrients are used, then the formulation is simple, but it fails to address the complexity of interacting factors in cognitive aging
Solution Approach 1:
The patent employs a composite nutritional formulation that integrates multiple bioactive compounds in specific proportions. This composite approach mirrors the complexity of biological systems, where cognitive health is influenced by interacting factors including oxidative stress, inflammation, vascular function, and neuronal metabolism. The synergistic interaction between components (e.g., omega-3s enhancing antioxidant efficacy, choline supporting B vitamin metabolism) allows the formulation to effectively address the multifactorial nature of cognitive aging while maintaining a unified, administrable product
Data Source
AI summary
A method of attenuating, treating or preventing cognitive aging in an individual who does not have dementia includes administering to the individual a therapeutically effective amount of a composition containing an omega-3 fatty acid and choline. The method can achieve a benefit that is one or more of decreasing brain atrophy, increasing or maintaining number of synapses, increasing amyloid-β phagocytosis, or decreasing or maintaining neuroinflammation in the non-demented individual. The method can prevent dementia in an individual at risk thereof, for example an elderly human. The composition can be administered to the individual in a daily dose that provides 5.5 mg/day to 5,500 mg/day of the choline, for example 85 mg/day to 3,500 mg/day of the choline.